These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16609139

  • 1. Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease.
    Iizuka M, Konno S, Horie Y, Itou H, Shindo K, Watanabe S.
    Gut; 2006 May; 55(5):744-5. PubMed ID: 16609139
    [No Abstract] [Full Text] [Related]

  • 2. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK, Han DS, Eun CS.
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract] [Full Text] [Related]

  • 3. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP, Chapman FA, Bellamy CO, Save V, Plevris JN, Shand AG, Whitworth C, Dhaun N.
    QJM; 2014 Jan; 107(1):57-9. PubMed ID: 23681221
    [No Abstract] [Full Text] [Related]

  • 4. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A, Zake T, Groma V, Ostrovskis E, Skuja S, Pokrotnieks J.
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [Abstract] [Full Text] [Related]

  • 5. Infliximab as disease-modifying therapy.
    D'Haens GR.
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):233-7. PubMed ID: 12610316
    [Abstract] [Full Text] [Related]

  • 6. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C, Calado J, Cravo M.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():15-7. PubMed ID: 21175229
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infliximab: how to use it in pediatric Crohn's disease.
    Ruemmele FM.
    J Pediatr Gastroenterol Nutr; 2004 Jul 14; 39(1):12-4. PubMed ID: 15187774
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
    Shanahan F.
    Inflamm Bowel Dis; 2000 May 14; 6(2):137-9. PubMed ID: 10833074
    [No Abstract] [Full Text] [Related]

  • 13. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F, Nagy F, Szepes Z, Kiss I, Lonovics J, Molnár T.
    Inflamm Bowel Dis; 2008 Mar 14; 14(3):429-31. PubMed ID: 17973302
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reactive hepatitis in a patient with Crohn's disease successfully treated with infliximab: does tumor necrosis factor alpha play a role in reactive hepatitis?
    Magro F, Pereira P, Carneiro F, Veloso FT.
    Inflamm Bowel Dis; 2005 Jan 14; 11(1):88-90. PubMed ID: 15674127
    [No Abstract] [Full Text] [Related]

  • 16. [Biological therapy to Crohn's disease with anti-tumor necrosis factor alpha].
    Matsumoto T, Oshitani N, Arakawa T.
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jan 14; 100(1):6-12. PubMed ID: 12601922
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
    Angelucci E, Cocco A, Viscido A, Caprilli R.
    Inflamm Bowel Dis; 2008 Mar 14; 14(3):435-6. PubMed ID: 18050300
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.